| |
Healthcare Resource Utilization and Costs of Hepatitis Delta in the United States: An Analysis of All-Payer Claims Database
|
| |
| |
EASL 2022 June 22-26 London
Joseph K. Lim,1 Vinod Rustgi,2 Robert G. Gish,3,4 Ira M. Jacobson,5 Ankita Kaushik,6 Yan Liu,6 Emily Achter,7 Robert Wong8
1Yale School of Medicine, New Haven, CT, US; 2Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, US; 3University of Nevada, Reno School of Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV, US; 4UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, Hepatitis B. Foundation, La Jolla, CA, US;
5NYU Grossman School of Medicine, New York, NY, US; 6Gilead Sciences, Inc., Foster City, CA, US; 7STATinMED, Plano, TX, US; 8Stanford University School of Medicine, Stanford, and VA Palo Alto Healthcare System, Palo Alto, CA, US
|
|
| |
| |
|
|
|
